Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-10-04-Speech-4-196"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20011004.9.4-196"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
". – I will put your objections to my colleagues. I also want to point out that what I have said reflects the way the Commission services, and the Commission as such, analyse this issue. I will repeat what I just said: "the Commission considers there are no imperative reasons why it should raise any objections, as the contested patent does not infringe essential ethical rules and concerns the field of application which can be granted to a patent relating to a DNA sequence".
Obviously there is, and may continue to be, disagreement. This is the reality in an area like this, and ten years of discussions leading up to the 1998 directive may not be enough to create a real, workable agreement. However, this is the legislation we have as our basis for action."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples